KAKEN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 4521 for the last quarter is 18.51 B JPY, and it's 2.74% higher compared to the previous quarter. The net income of Q3 23 is 2.61 B JPY.